In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
Biomaterials
; 291: 121876, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36334354
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Biomaterials
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands